Chronic Myelogenous Leukemia
New chronic myelogenous leukemia research from D.E. Westfall and colleagues discussed
Published in Blood Weekly, July 24th, 2008
"The incidence ranges from 0% to 33% in accordance with literature reports. The diagnosis of erythroid or megakaryocytic blast phase is often challenging because the percentage of blasts in the blood or bone marrow required for diagnosis has not been firmly established. Also, some myeloblasts can have aberrant expression of either erythroid...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2008-07-24)
More Articles from Blood Weekly
- McGill University
Gene therapy research in developing world raises ethical red flags: experts - Scripps Research Institute
Scripps research scientists reveal key structure from ebola virus - University of Pittsburgh Schools of the Health Sciences
Hepatitis C virus may need enzyme's help to cause liver disease - Attention Deficit Hyperactivity Disorder
Head-to-head study demonstrates Focalin® XR offers faster and better symptom control than Concerta® in early part of ADHD patients day - Autoimmune Hemolytic Anemia
Study findings from University of Connecticut broaden understanding of autoimmune hemolytic anemia - Bipolar Disorder
Scientists at Tampere University target bipolar disorder - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
